Effects of preoperative exercise on lung cancer patients
Official title: Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients(PRE-EXELUCA): a Prospective Randomized Controlled Clinical Trial
Run by Guangdong Provincial People's Hospital · NCT06215326 · Data updated 2026-11-12
This study is testing whether different levels of exercise before surgery can help lung cancer patients breathe better and recover more quickly after their operation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Guangdong Provincial People's Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | January 23, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | July 31, 2027 |
| Registry record updated | August 3, 2026 |
| Trial ID | NCT06215326 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with suspected or confirmed primary lung cancer and moderate-to-high perioperative risk.
✕Probably not a fit
Patients with concurrent malignancies, severe comorbidities, or those unable to participate in exercise training may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the impact of different intensities of preoperative exercise training on cardiorespiratory function and postoperative outcomes in lung cancer patients at moderate-to-high perioperative risk. Participants will be randomized into three groups: moderate-intensity continuous training (MICT), high-intensity interval training (HIIT), or usual care (UC). The study will involve 12 sessions of supervised exercise for the MICT and HIIT groups, while the UC group will not receive additional rehabilitation. Outcomes will be assessed through various measures, including cardiopulmonary exercise function and patient-reported outcomes, at multiple time points throughout the study.
Why it matters
Potential benefit: If successful, this study could improve postoperative recovery and overall outcomes for lung cancer patients undergoing surgery.
How similar studies have gone: Previous studies have shown positive outcomes with preoperative exercise interventions in surgical patients, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age\>18 years. 2. Suspected or confirmed primary lung cancer with scheduled surgical treatment. 3. Moderate-to-high perioperative risk, defined as FEV1\<60% of predicted value (wedge) or ppo FEV1\<60% of predicted value (lobectomy/segmentectomy) or VO2peak\<20 ml/kg/ min. 4. Sign informed consent and accept to comply with the requirements of the study protocol. 5. Completion of a baseline Complete cardiopulmonary exercise testing (CPET). Exclusion Criteria: 1. Concurrent or previous history of other malignant tumors. 2. Life expectancy less than 1 year. 3. Dementia; infirmity; or inability to participate in sports (musculoskeletal limitations, namely, injuries, frailty, and weakness). 4. Inability to maintain exercise training. 5. Irregular vital signs (heart rate: \< 40 or \> 120 bpm at rest; blood pressure: systolic blood pressure \> 200 mm Hg or diastolic pressure \> 110 mm Hg; T: ≥ 38.5 or ≤ 36◦C; SpO2 ≤ 90%). 6. Currently enrolling in any other clinical trials. 7. Patient refusal.
Where it's running
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Huan Ma, PhD
- Email: mahuandoctor@163.com
- Phone: +86 15078755932
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.